SensNews Feb 2016

Sensor100

February 2016

Philips to introduce next-generation monitoring solution

enabled by wearable biosensors

Royal Philips

announced that it will intro-

duce a next-generation monitoring solution

for at-risk patients in low acuity hospital

settings, such as the general ward. As an

industry-first, the new medical-grade biosen-

sor enabled solution demonstrates Philips’

continuing commitment to better address-

ing clinicians’ and patients’ needs through

monitoring. Unlike fitness trackers and

consumer focused wearables, the new medi-

cal-grade, connected biosensor automatically

and continuously measures clinically relevant vital signs including heart rate, respiratory

rate, skin temperature and more.The biosensor then transmits the data it collects to

a connected clinical decision support software application, where the software can be

configured to promptly notify the appropriate caregiver or clinician when preset limits

are exceeded.

22 February

AstraeusTechnologies wins MIT $100KAccelerate with

new lung cancer test

Astraeus Technologies won both the $10,000

Danny Lewin Grand Prize and the $3,000

Founders.org Audience Choice Prize Feb. 10

with a device, the L-Card, that can detect lung

cancer through a single breath. The L-Card,

slightly larger than a postage stamp, detects

chemicals in human breath.The card is then

read by a smart phone application that indicates

high levels of cancer indicators. The Astraeus

team said the single-use cards can be manufac-

tured for about $1, and may be as much as 10 times more accurate than CT scans.

11 February